{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 459985202
| IUPAC_name = 16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11-β,16-α)-pregna-1,4-diene-3,20-dione
| image = Budesonid Grundstruktur V4.svg
| width = 250
| image2 = Budesonide ball-and-stick.png
| width2 = 250

<!--Clinical data-->
| tradename = Pulmicort, Rhinocort, Entocort, others
| Drugs.com = {{drugs.com|monograph|budesonide}}
| MedlinePlus = a608007
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = B
| pregnancy_category =  
| licence_EU = yes
| legal_AU = S2
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = OTC
| legal_US_comment = and Rx-only
| routes_of_administration = By mouth, nasal, tracheal, rectal

<!--Pharmacokinetic data-->
| bioavailability = 10-20%（首渡效應）
| protein_bound = 85-90%
| metabolism = 肝臟（[[CYP3A4|CYP3A4]]）
| elimination_half-life = 2.0-3.6 hours
| excretion = [[尿|尿]]、[[糞便|糞便]]

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 51333-22-3
| ATC_prefix = A07
| ATC_suffix = EA06
| ATC_supplemental =  {{ATC|D07|AC09}}, {{ATC|R01|AD05}}, {{ATC|R03|BA02}}
| PubChem = 40000
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01222
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 4444479
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Q3OKS62Q6X
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00246
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1370
| PDB_ligand = 8W5

<!--Chemical data-->
| C=25 | H=34 | O=6
| molecular_weight = 430.534 g/mol
| SMILES = CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = VOVIALXJUBGFJZ-KWVAZRHASA
| synonyms = 11β,21-Dihydroxy-16α,17α-(butylidenebis(oxy))pregna-1,4-diene-3,20-dione
}}
<!-- Definition and medical uses -->
'''布地奈德'''（Budesonide），常見商品名'''Pulmicort'''，是一种[[肾上腺皮质激素|肾上腺皮质激素]]类药<ref name=AHFS2015/>。本品可以製成{{tsl|en|metered-dose inhaler|定量吸入劑}}、藥丸、{{tsl|en|nasal spray|鼻內噴劑}}，以及肛門塞劑等等<ref name=AHFS2015>{{cite web|title=Budesonide|url=https://www.drugs.com/monograph/budesonide.html|publisher=The American Society of Health-System Pharmacists|accessdate=Dec 2, 2015|deadurl=no|archiveurl=https://web.archive.org/web/20151128150235/http://www.drugs.com/monograph/budesonide.html|archivedate=2015-11-28|df=}}</ref><ref name=AHFS2015ENT>{{cite web|title=Budesonide eent|url=https://www.drugs.com/monograph/budesonide-eent.html|publisher=The American Society of Health-System Pharmacists|accessdate=Dec 2, 2015|deadurl=no|archiveurl=https://web.archive.org/web/20151208195318/http://www.drugs.com/monograph/budesonide-eent.html|archivedate=2015-12-08|df=}}</ref>。吸入劑型長期使用可用於治療[[哮喘|哮喘]]及[[慢性阻塞性肺病|慢性阻塞性肺病]]<ref name=AHFS2015 /><ref>{{cite journal|last1=De Coster|first1=DA|last2=Jones|first2=M|title=Tailoring of corticosteroids in COPD management.|journal=Current respiratory care reports|date=2014|volume=3|pages=121–132|pmid=25089228|doi=10.1007/s13665-014-0084-2|pmc=4113685}}</ref><ref>{{cite journal|last1=Christophi|first1=GP|last2=Rengarajan|first2=A|last3=Ciorba|first3=MA|title=Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach.|journal=Clinical and experimental gastroenterology|date=2016|volume=9|pages=125–30|pmid=27274301|doi=10.2147/CEG.S80237|pmc=4876845}}</ref>。鼻噴劑則可用於治療[[過敏性鼻炎|過敏性鼻炎]]和[[鼻息肉|鼻息肉]]<ref name=AHFS2015ENT/><ref>{{cite journal|last1=Rudmik|first1=L|last2=Schlosser|first2=RJ|last3=Smith|first3=TL|last4=Soler|first4=ZM|title=Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis.|url=https://archive.org/details/sim_laryngoscope_2012-07_122_7/page/1431|journal=The Laryngoscope|date=July 2012|volume=122|issue=7|pages=1431–7|pmid=22410935|doi=10.1002/lary.23259}}</ref>。緩釋型肛門塞劑可用於治療[[克隆氏症|克隆氏症]]、[[溃疡性结肠炎|溃疡性结肠炎]]，以及{{tsl|en|microscopic colitis|微小性結腸炎}}等[[炎症性肠病|炎症性肠病]]<ref name=Sil2011>{{cite journal|vauthors=Silverman J, Otley A | title=Budesonide in the treatment of inflammatory bowel disease. | journal=Expert Rev Clin Immunol | year= 2011 | volume= 7 | issue= 4 | pages= 419–28 | pmid=21790284 | doi=10.1586/eci.11.34 | pmc= }}</ref><ref>{{cite journal |vauthors=Pardi DS, Tremaine WJ, Carrasco-Labra A |title=American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis |journal=Gastroenterology |volume=150 |issue=1 |pages=247–274.e11 |year=2016 |pmid=26584602 |doi=10.1053/j.gastro.2015.11.006 |url=}}</ref><ref name=BNF58>{{cite book|title=British national formulary : BNF 58|date=2009|publisher=British Medical Association|isbn=9780857111562|pages=56-57|edition=58}}</ref>。

<!-- Side effects and mechanism -->
吸入劑型常見副作用包含吸入性肺炎、咳嗽，以及頭痛<ref name=AHFS2015/>。錠劑型的常見副作用則包含疲憊、嘔吐，以及關節疼痛<ref name=AHFS2015/>。嚴重副作用包含感染風險上升、骨強度下降，以及[[白内障|白内障]]<ref name=AHFS2015/>。長期服用錠劑可能會導致{{tsl|en|adrenal insufficiency|腎上腺機能不足}}<ref name=AHFS2015/>。因此長期使用錠劑者，驟然停用相當危險<ref name=AHFS2015/>。[[妊娠|妊娠]]期間使用吸入劑型顯示為安全<ref name=AHFS2015/>，本品為一種[[糖皮质激素|糖皮质激素]]類藥物<ref name=AHFS2015/>。

<!-- Society and culture -->
本品最早於1973年取得專利<ref>{{cite book|last1=Domeij|first1=Bengt|title=Pharmaceutical patents in Europe|date=2000|publisher=Kluwer Law International|location=The Hague|isbn=9789041113481|page=278|url=https://books.google.ca/books?id=KZfvZN2WfjcC&pg=PA278|deadurl=no|archiveurl=https://web.archive.org/web/20151208072850/https://books.google.ca/books?id=KZfvZN2WfjcC&pg=PA278|archivedate=2015-12-08|df=}}</ref>，並於1981年開始上市用於治療氣喘<ref>{{cite book|last1=Hamley|first1=Peter|title=Small Molecule Medicinal Chemistry: Strategies and Technologies|date=2015|publisher=John Wiley & Sons|isbn=9781118771693|page=390|url=https://books.google.ca/books?id=LOudCgAAQBAJ&pg=PA390|deadurl=no|archiveurl=https://web.archive.org/web/20151208062120/https://books.google.ca/books?id=LOudCgAAQBAJ&pg=PA390|archivedate=2015-12-08|df=}}</ref>。本品列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]之中，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref>。本品屬於[[通用名药物|通用名药物]]<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=451}}</ref>。2014年，含200劑量的吸入劑型於[[发展中国家|发展中国家]]的批發價約介於5至7美金之間<ref>{{cite web|title=Budesonide|url=http://mshpriceguide.org/en/single-drug-information/?DMFId=1406&searchYear=2014|website=International Drug Price Indicator Guide|accessdate=5 December 2015|archive-date=2020-07-11|archive-url=https://web.archive.org/web/20200711111138/https://mshpriceguide.org/en/single-drug-information/?DMFId=1406&searchYear=2014|dead-url=no}}</ref>。在2015年的美國，一個月的正常劑量售價約界於100至200美金之間<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=451}}</ref>。

==适应症==
*滴鼻剂用于季节性和慢性过敏性鼻炎，血管舒缩性鼻炎，鼻息肉切除后预防[[息肉|息肉]]再生
*气雾剂用于慢性哮喘
*外用剂型用于[[皮肤炎|皮肤炎]]性疾病
*胶囊：治疗轻度到中度的活跃[[克罗恩病|克罗恩病]]。[http://www.fda.gov/bbs/topics/ANSWERS/2001/ANS01106.html] {{Wayback|url=http://www.fda.gov/bbs/topics/ANSWERS/2001/ANS01106.html |date=20090218225329 }}

==用法用量==
*[[喷鼻剂|喷鼻剂]]/[[滴鼻剂|滴鼻剂]]
**每个[[鼻孔|鼻孔]]各喷2次，达到效果后，每个鼻孔各喷1次，每日两次
*[[气雾剂|气雾剂]]
**成人
***起始剂量100~200μg/次，每日2次
***维持量200~400μg/次，每日2次
**[[儿童|儿童]]
***起始剂量200~800μg/次，每日2次
*[[药膏|药膏]]
**涂于患处

==注意事项==
*[[呼吸道|呼吸道]][[真菌|真菌]]、[[病毒|病毒]]感染，[[结核病|结核病]]患者，儿童、孕妇及哺乳妇女慎用

==不良反应==
*气雾剂
**少见声音嘶哑，口咽部[[念珠菌|念珠菌]]感染
*喷鼻剂/滴鼻剂
**偶见[[打喷嚏|打喷嚏]]或鼻腔少量血性分泌物
*吸后彻底漱口可使不良反应率减至最低。如果发现口咽念珠菌病，可用适当的抗真菌药治疗，并继续使用布地奈德。

==相关评价与研究==
*长期低剂量吸入布地奈德对轻度哮喘的儿童防止运动诱发的[[支气管|支气管]]收缩较为安全有效，并使其肺功能几乎达到正常。仅对7-11岁的儿童生长发育速度有明显的作用。
*小剂量[[皮质激素|皮质激素]]是当前最有效的抗过敏药物，吸入布地缩松气雾剂对减轻甚至消除气道炎症与气道高反应性有较好的疗效。
*轻型哮喘的患者应用低剂量的吸入性皮质类固醇布地奈德就会有显著的抗炎活性，加上长效β-2显效药[[福莫特罗|福莫特罗]]或增加布地奈德的剂量不会产生明显的附加抗炎效果。
*布地奈德与福莫特罗两种药物的联合治疗是被[[美国哮喘教育和预防项目|美国哮喘教育和预防项目]]（NAEPP）所推荐的，能够长时间控制和防止中度至重度永久性哮喘病症状的发生。
*从长远来看，这种治疗不会影响儿童的身高。由于吸入性类固醇对骨胳生长的影响与对器官生长的影响不一定相同，建议在没有更多地了解吸入性类固醇对内脏器官有何影响之前，不要对有轻度哮喘的幼儿使用该类药物。

[[File:BudesonideNasalSpray.png|缩略图]]
<br />
==參見==
* {{tsl|en|Azelastine||Azelastine}}
* {{tsl|en|Fluticasone propionate||Fluticasone propionate}}

==參考文獻==
{{Reflist}}

==外部連結==
* [https://web.archive.org/web/20100216094309/http://www.entocortec.com/PDF/ENTOCORT_PI.pdf Entocort EC Prescribing information] Prometheus Laboratories (PDF)
* [http://www.nlm.nih.gov/medlineplus/druginfo/meds/a608007.html Budesonide Oral (Entocort EC)] {{Wayback|url=http://www.nlm.nih.gov/medlineplus/druginfo/meds/a608007.html |date=20160705112014 }} [[MedlinePlus|MedlinePlus]], [[國立衛生研究院_(美國)|National Institutes of Health]] (NIH), [[美国国家医学图书馆|U.S. National Library of Medicine]]
* [http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601030.html Budesonide Nasal Spray (Rhinocort)] {{Wayback|url=http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601030.html |date=20160705112013 }} [[MedlinePlus|MedlinePlus]], [[國立衛生研究院_(美國)|National Institutes of Health]] (NIH), [[美国国家医学图书馆|U.S. National Library of Medicine]]
* [http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601030.html Budesonide Oral Inhalation (Symbicort)] {{Wayback|url=http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601030.html |date=20160705112013 }} [[MedlinePlus|MedlinePlus]], [[國立衛生研究院_(美國)|National Institutes of Health]] (NIH), [[美国国家医学图书馆|U.S. National Library of Medicine]]

{{Glucocorticoids}}
{{Antidiarrheals, intestinal anti-inflammatory/anti-infective agents}}
<!--{{Nasal preparations}}-->
{{Asthma_and_copd_rx}}
{{Glucocorticoidics}}
<!--{{AstraZeneca}}-->

[[Category:抗喘药|Category:抗喘药]]
[[Category:阿斯利康制药|Category:阿斯利康制药]]
[[Category:皮质类固醇|Category:皮质类固醇]]
[[Category:二醇|Category:二醇]]
[[Category:糖皮质激素|Category:糖皮质激素]]
[[Category:孕烷|Category:孕烷]]